CFR-600

From WikiMD's Food, Medicine & Wellnesspedia

CFR-600 is a type of nuclear reactor designed for fast neutron spectrum and cooled by liquid sodium. It is a part of the Generation IV reactor initiative and is being developed by Rosatom, the Russian state nuclear energy corporation. The CFR-600 is a pool-type reactor, with the reactor core, primary pumps, and intermediate heat exchangers all located within a single pool of liquid sodium.

Design and Operation[edit | edit source]

The CFR-600 is designed to operate with a thermal power of 1500 MW and an electrical power of 600 MW. The reactor core is composed of MOX fuel, a mixture of plutonium and uranium oxides. The use of MOX fuel allows the reactor to breed more fuel than it consumes, making it a breeder reactor.

The reactor is cooled by liquid sodium, which has excellent heat transfer properties and does not slow down neutrons as much as other coolants, allowing the reactor to operate in a fast neutron spectrum. This enables the reactor to burn long-lived radioactive waste, reducing the amount of waste that needs to be stored.

Safety Features[edit | edit source]

The CFR-600 includes several safety features, such as a passive cooling system that can remove heat from the reactor core without the need for active mechanical systems. The reactor also includes a core catcher, a device designed to contain the reactor core in the event of a meltdown.

Development and Future Plans[edit | edit source]

The development of the CFR-600 is part of Russia's plan to transition to a closed nuclear fuel cycle, where all spent nuclear fuel is reprocessed and reused. The first CFR-600 reactor is currently under construction in Beloyarsk, Russia, and is expected to be operational by 2026.

See Also[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD